Evidence map›Paper›PMID 25491284›Full record

ArticleJournal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry2015

Phosphorus-nitrogen compounds: part 30. Syntheses and structural investigations, antimicrobial and cytotoxic activities and DNA interactions of vanillinato-substituted NN or NO spirocyclic monoferrocenyl cyclotriphosphazenes.

Yasemin Tümer, L Yasemin Koç, Nuran Asmafiliz, Zeynel Kılıç, Tuncer Hökelek, Hossien Soltanzade, Leyla Açık, Mehmet Lütfi Yola, Ali Osman Solak

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yasemin TümerDepartment of Chemistry, Karabük University, 78050, Karabük, Turkey.
L Yasemin KoçDepartment of Biology, Ankara University, 06100, Ankara, Turkey.
Nuran AsmafilizDepartment of Chemistry, Ankara University, 06100, Ankara, Turkey.
Zeynel KılıçDepartment of Chemistry, Ankara University, 06100, Ankara, Turkey. zkilic@science.ankara.edu.tr.
Tuncer HökelekDepartment of Physics, Hacettepe University, 06800, Ankara, Turkey.
Hossien SoltanzadeDepartment of Biology, Gazi University, 06500, Ankara, Turkey.
Leyla AçıkDepartment of Biology, Gazi University, 06500, Ankara, Turkey.
Mehmet Lütfi YolaDepartment of Metallurgical and Materials Engineering, Sinop University, 57000, Sinop, Turkey.
Ali Osman SolakDepartment of Chemical Engineering, Kyrgyzstan-Turkey Manas University, Bishkek, Kyrgyzstan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The gradual Cl replacement reactions of NN (1-3) or NO spirocyclic monoferrocenyl cyclotriphosphazenes (4 and 5) with the potassium salt of 4-hydroxy-3-methoxybenzaldehyde (potassium vanillinate) resulted in the mono (1a-5a), geminal (gem-1b-5b), non-geminal (cis-5b and trans -1b-4b), tri (1c, 3c-5c) and tetra-vanillinato-substituted phosphazenes (1d-5d). All the phosphazene derivatives have stereogenic P-center(s), except tetra-substituted ones. The vanillinatophosphazenes have reversible voltammograms with one-electron anodic and cathodic peaks which are attributed to ferrocenyl redox probe. The structures of the new phosphazene compounds were determined by FTIR, MS, (1)H, (13)C{(1)H} and (31)P{(1)H} NMR spectral data. The solid-state structure of cis -5b was examined by single-crystal X-ray diffraction techniques. In addition, the compounds were tested in HeLa cancer cell lines using MTT assay. The 12 phosphazene derivatives were screened for antimicrobial activity, and 3c was very effective against S. aureus even at 4.88 µM concentration, taking into account the MIC values. Besides, interactions between the phosphazenes and pBR322 plasmid DNA were also investigated.

Indexed as

Anti-Bacterial AgentsAntineoplastic AgentsBacillus subtilisBenzaldehydesCell SurvivalCrystallography, X-RayDNADrug Screening Assays, AntitumorFerrous CompoundsHeLa CellsHumansMicrobial Sensitivity TestsMicrobial ViabilityMolecular ConformationOrganophosphorus CompoundsPlasmidsAnti-Bacterial AgentsAntineoplastic AgentsBenzaldehydesDNAFerrous CompoundsOrganophosphorus Compounds

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.